These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 16166301)
1. Essential role for Ras signaling in glioblastoma maintenance. Holmen SL; Williams BO Cancer Res; 2005 Sep; 65(18):8250-5. PubMed ID: 16166301 [TBL] [Abstract][Full Text] [Related]
2. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767 [TBL] [Abstract][Full Text] [Related]
3. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Holland EC; Celestino J; Dai C; Schaefer L; Sawaya RE; Fuller GN Nat Genet; 2000 May; 25(1):55-7. PubMed ID: 10802656 [TBL] [Abstract][Full Text] [Related]
4. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis. Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613 [TBL] [Abstract][Full Text] [Related]
5. GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background. Hede SM; Hansson I; Afink GB; Eriksson A; Nazarenko I; Andrae J; Genove G; Westermark B; Nistér M Glia; 2009 Aug; 57(11):1143-53. PubMed ID: 19115382 [TBL] [Abstract][Full Text] [Related]
6. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis. Ferletta M; Uhrbom L; Olofsson T; Pontén F; Westermark B Mol Cancer Res; 2007 Sep; 5(9):891-7. PubMed ID: 17855658 [TBL] [Abstract][Full Text] [Related]
7. Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. Cobbs CS; Soroceanu L; Denham S; Zhang W; Kraus MH Cancer Res; 2008 Feb; 68(3):724-30. PubMed ID: 18245472 [TBL] [Abstract][Full Text] [Related]
8. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180 [TBL] [Abstract][Full Text] [Related]
9. Transgenic mice carrying the human KRAS oncogene under the control of a thyroglobulin promoter: KRAS expression in thyroids analyzed by in situ hybridization. Chiappetta G; Fabien N; Picone A; Califano D; Monaco C; de Franciscis V; Vecchio G; Santelli G Oncol Res; 1996; 8(2):85-93. PubMed ID: 8859779 [TBL] [Abstract][Full Text] [Related]
10. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways. Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183 [TBL] [Abstract][Full Text] [Related]
11. Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. Janzarik WG; Kratz CP; Loges NT; Olbrich H; Klein C; Schäfer T; Scheurlen W; Roggendorf W; Weiller C; Niemeyer C; Korinthenberg R; Pfister S; Omran H Neuropediatrics; 2007 Apr; 38(2):61-3. PubMed ID: 17712732 [TBL] [Abstract][Full Text] [Related]
12. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Fan X; Matsui W; Khaki L; Stearns D; Chun J; Li YM; Eberhart CG Cancer Res; 2006 Aug; 66(15):7445-52. PubMed ID: 16885340 [TBL] [Abstract][Full Text] [Related]
13. Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance. Lim KH; Counter CM Cancer Cell; 2005 Nov; 8(5):381-92. PubMed ID: 16286246 [TBL] [Abstract][Full Text] [Related]
14. Modeling and preclinical trials for gliomas. Salpietro M; Holland EC Clin Neurosurg; 2005; 52():104-11. PubMed ID: 16626060 [No Abstract] [Full Text] [Related]
16. c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells. Cui J; Han SY; Wang C; Su W; Harshyne L; Holgado-Madruga M; Wong AJ Cancer Res; 2006 Oct; 66(20):10024-31. PubMed ID: 17047065 [TBL] [Abstract][Full Text] [Related]
17. Oncogenic KRAS promotes malignant brain tumors in zebrafish. Ju B; Chen W; Orr BA; Spitsbergen JM; Jia S; Eden CJ; Henson HE; Taylor MR Mol Cancer; 2015 Feb; 14(1):18. PubMed ID: 25644510 [TBL] [Abstract][Full Text] [Related]